Schedule 13G ownership disclosure
ROYALTY PHARMA PLC- CL A
Common Stock · CUSIP: G7709Q104
Event date: 2025-09-30
- Filing-level shares
- 10,936,538
- Percent of class
- 2.52%
- The Vanguard Group
Shares: 10,936,538 · Class: 2.52%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000102909-25-000191
- Form type
- SCHEDULE 13G/A
- Filer
- Royalty Pharma plc
- CIK
- CIK 1802768
- Filed
- Oct 30, 2025
- Reporting period
- Sep 30, 2025
- Description
- Schedule 13G beneficial ownership